Invasive mucormycosis during COVID-19 infection. Report of two cases
COVID-19 disease is associated with a significant number of opportunistic infections, including invasive fungal infections such as mucormycosis. The prevalence of the latter is rare, estimated to be between 0.005 and 1.7 per million inhabitants. Risk factors include hematological diseases, Diabetes Mellitus with poor metabolic control, solid organ transplantation, neutropenia, and prolonged administration of systemic corticosteroids. We report two males aged 60 and 75 years with pulmonary and tracheobronchial invasive mucormycosis, respectively. Both patients had a deficient metabolic control of their diabetes as a predisposing risk factor added to severe COVID-19 infection. High suspicion and early diagnosis are essential for prompt treatment, especially considering the associated high morbidity and mortality of this fungal infection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:151 |
|---|---|
| Enthalten in: |
Revista medica de Chile - 151(2023), 1 vom: 02. Feb., Seite 125-128 |
| Sprache: |
Spanisch |
|---|
| Weiterer Titel: |
Mucormicosis invasora en pacientes con COVID-19: reporte de 2 casos |
|---|
| Beteiligte Personen: |
Camhi, Dana [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.01.2024 Date Revised 23.01.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4067/s0034-98872023000100125 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36398688X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36398688X | ||
| 003 | DE-627 | ||
| 005 | 20240124231949.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||spa c | ||
| 024 | 7 | |a 10.4067/s0034-98872023000100125 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1269.xml |
| 035 | |a (DE-627)NLM36398688X | ||
| 035 | |a (NLM)37906754 | ||
| 035 | |a (PII)S0034-98872023000100125 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a spa | ||
| 100 | 1 | |a Camhi, Dana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Invasive mucormycosis during COVID-19 infection. Report of two cases |
| 246 | 3 | 3 | |a Mucormicosis invasora en pacientes con COVID-19: reporte de 2 casos |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.01.2024 | ||
| 500 | |a Date Revised 23.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a COVID-19 disease is associated with a significant number of opportunistic infections, including invasive fungal infections such as mucormycosis. The prevalence of the latter is rare, estimated to be between 0.005 and 1.7 per million inhabitants. Risk factors include hematological diseases, Diabetes Mellitus with poor metabolic control, solid organ transplantation, neutropenia, and prolonged administration of systemic corticosteroids. We report two males aged 60 and 75 years with pulmonary and tracheobronchial invasive mucormycosis, respectively. Both patients had a deficient metabolic control of their diabetes as a predisposing risk factor added to severe COVID-19 infection. High suspicion and early diagnosis are essential for prompt treatment, especially considering the associated high morbidity and mortality of this fungal infection | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a López, María Ignacia |e verfasserin |4 aut | |
| 700 | 1 | |a Wiener, Alan |e verfasserin |4 aut | |
| 700 | 1 | |a Heinriksen, Karin |e verfasserin |4 aut | |
| 700 | 1 | |a Pérez, Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a Verdugo, Fernando |e verfasserin |4 aut | |
| 700 | 1 | |a Rosas, Reinaldo |e verfasserin |4 aut | |
| 700 | 1 | |a Farías, Pamela |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Revista medica de Chile |d 1945 |g 151(2023), 1 vom: 02. Feb., Seite 125-128 |w (DE-627)NLM00019624X |x 0717-6163 |7 nnns |
| 773 | 1 | 8 | |g volume:151 |g year:2023 |g number:1 |g day:02 |g month:02 |g pages:125-128 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4067/s0034-98872023000100125 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 151 |j 2023 |e 1 |b 02 |c 02 |h 125-128 | ||